InvestLog
NUVB logo

NUVB

Nuvation Bio Inc.NYSEHealthcare
$4.41-2.22%ClosedMarket Cap: $1.53B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-27Wedbush—Outperform—
2026-03-03RBC Capital—Outperform—
2026-03-03UBS—Neutral—
2026-02-10Wedbush—Outperform—
2026-01-21RBC Capital—Outperform—
2026-01-12HC Wainwright & Co.—Buy—
2025-12-11HC Wainwright & Co.—Buy—
2025-11-20Citizens—Market Outperform—
2025-11-04RBC Capital—Outperform—
2025-10-13Wedbush—Outperform—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.26$295.4M5
Sun Dec 31$-0.12$406.6M6
Mon Dec 31$0.04$501.0M4
Tue Dec 31$0.32$668.4M2